These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 7567922)

  • 61. The 1.85 A resolution crystal structures of tissue factor in complex with humanized Fab D3h44 and of free humanized Fab D3h44: revisiting the solvation of antigen combining sites.
    Faelber K; Kirchhofer D; Presta L; Kelley RF; Muller YA
    J Mol Biol; 2001 Oct; 313(1):83-97. PubMed ID: 11601848
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Rigid-body docking with mutant constraints of influenza hemagglutinin with antibody HC19.
    Cherfils J; Bizebard T; Knossow M; Janin J
    Proteins; 1994 Jan; 18(1):8-18. PubMed ID: 7511810
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Development and validation of a genetic algorithm for flexible docking.
    Jones G; Willett P; Glen RC; Leach AR; Taylor R
    J Mol Biol; 1997 Apr; 267(3):727-48. PubMed ID: 9126849
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Hydrophobic docking: a proposed enhancement to molecular recognition techniques.
    Vakser IA; Aflalo C
    Proteins; 1994 Dec; 20(4):320-9. PubMed ID: 7731951
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Principles of docking: An overview of search algorithms and a guide to scoring functions.
    Halperin I; Ma B; Wolfson H; Nussinov R
    Proteins; 2002 Jun; 47(4):409-43. PubMed ID: 12001221
    [TBL] [Abstract][Full Text] [Related]  

  • 66. High resolution structures of the 4-4-20 Fab-fluorescein complex in two solvent systems: effects of solvent on structure and antigen-binding affinity.
    Herron JN; Terry AH; Johnston S; He XM; Guddat LW; Voss EW; Edmundson AB
    Biophys J; 1994 Dec; 67(6):2167-83. PubMed ID: 7696460
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Modeling the binding sites of anti-hen egg white lysozyme antibodies HyHEL-8 and HyHEL-26: an insight into the molecular basis of antibody cross-reactivity and specificity.
    Mohan S; Sinha N; Smith-Gill SJ
    Biophys J; 2003 Nov; 85(5):3221-36. PubMed ID: 14581222
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Protein-inhibitor flexible docking by a multicanonical sampling: native complex structure with the lowest free energy and a free-energy barrier distinguishing the native complex from the others.
    Kamiya N; Yonezawa Y; Nakamura H; Higo J
    Proteins; 2008 Jan; 70(1):41-53. PubMed ID: 17636570
    [TBL] [Abstract][Full Text] [Related]  

  • 69. A model binding site for testing scoring functions in molecular docking.
    Wei BQ; Baase WA; Weaver LH; Matthews BW; Shoichet BK
    J Mol Biol; 2002 Sep; 322(2):339-55. PubMed ID: 12217695
    [TBL] [Abstract][Full Text] [Related]  

  • 70. A soft docking algorithm for predicting the structure of antibody-antigen complexes.
    Li CH; Ma XH; Chen WZ; Wang CX
    Proteins; 2003 Jul; 52(1):47-50. PubMed ID: 12784367
    [TBL] [Abstract][Full Text] [Related]  

  • 71. DARWIN: a program for docking flexible molecules.
    Taylor JS; Burnett RM
    Proteins; 2000 Nov; 41(2):173-91. PubMed ID: 10966571
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Protein-protein docking by simulating the process of association subject to biochemical constraints.
    Motiejunas D; Gabdoulline R; Wang T; Feldman-Salit A; Johann T; Winn PJ; Wade RC
    Proteins; 2008 Jun; 71(4):1955-69. PubMed ID: 18186463
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Structural Analysis of Der p 1-Antibody Complexes and Comparison with Complexes of Proteins or Peptides with Monoclonal Antibodies.
    Osinski T; Pomés A; Majorek KA; Glesner J; Offermann LR; Vailes LD; Chapman MD; Minor W; Chruszcz M
    J Immunol; 2015 Jul; 195(1):307-16. PubMed ID: 26026055
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Refined crystal structure of the influenza virus N9 neuraminidase-NC41 Fab complex.
    Tulip WR; Varghese JN; Laver WG; Webster RG; Colman PM
    J Mol Biol; 1992 Sep; 227(1):122-48. PubMed ID: 1381757
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Refined 1.6 A resolution crystal structure of the complex formed between porcine beta-trypsin and MCTI-A, a trypsin inhibitor of the squash family. Detailed comparison with bovine beta-trypsin and its complex.
    Huang Q; Liu S; Tang Y
    J Mol Biol; 1993 Feb; 229(4):1022-36. PubMed ID: 8445634
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Modeling oligomers with Cn or Dn symmetry: application to CAPRI target 10.
    Berchanski A; Segal D; Eisenstein M
    Proteins; 2005 Aug; 60(2):202-6. PubMed ID: 15981250
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Hierarchical modeling of protein interactions.
    Kurcinski M; Kolinski A
    J Mol Model; 2007 Jul; 13(6-7):691-8. PubMed ID: 17297609
    [TBL] [Abstract][Full Text] [Related]  

  • 78. ABGEN: a knowledge-based automated approach for antibody structure modeling.
    Mandal C; Kingery BD; Anchin JM; Subramaniam S; Linthicum DS
    Nat Biotechnol; 1996 Mar; 14(3):323-8. PubMed ID: 9630894
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Predicting molecular interactions and inducible complementarity: fragment docking of Fab-peptide complexes.
    Friedman AR; Roberts VA; Tainer JA
    Proteins; 1994 Sep; 20(1):15-24. PubMed ID: 7529922
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Solvent accessible surface representation in a database system for protein docking.
    Seidl T; Kriegel HP
    Proc Int Conf Intell Syst Mol Biol; 1995; 3():350-8. PubMed ID: 7584458
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.